NCT03471572View on ClinicalTrials.gov

Study to Assess Prevalence of BRCA1 and BRCA2 Mutation Among Ovarian, Primary Peritoneal and Fallopian Tube Cancer Patients in India

CompletedOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

March 22, 2018

Primary Completion Date

December 21, 2018

Study Completion Date

December 21, 2018

Conditions
Ovarian Cancer
Trial Locations (8)

110005

Research Site, Delhi

110017

Research Site, Delhi

110060

Research Site, Delhi

400012

Research Site, Mumbai

400071

Research Site, Mumbai

500034

Research Site, Hyderabad

560027

Research Site, Bangalore

700099

Research Site, Kolkata

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY